MedTrace Logo

Ureteral Stent Size Measurement Study

NCT00919386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2015-07-31

No results posted yet for this study

Summary

To examine a patient's quality of life using three methods for measuring stent size: (a) direct measurement, (b) patient height, and (c) a standardized formula. The intent of the study is to show if there is a difference in a patient's quality of life, postoperative symptoms, pain medication and anticholinergic use by using one of these specific methods for stent size determination. No method is interventional in this study.

Conditions

  • Quality of Life

Sponsors & Collaborators

  • CAMC Health System

    lead OTHER

Principal Investigators

  • Samuel Deem, M.D. · CAMC Medical Staff - with admitting privileges

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00919386 on ClinicalTrials.gov